Dr. Gillett and Nurse Practitioner James O'Hara delve into the reasons why withholding the publication of studies can be detrimental.

00:00 Intro

01:05 Undisclosed Human Study

07:07 Rapamycin and Ketamine Combination

15:50 Lifespan Impact: SIRT2 Transgenic Over-expression in Mice

18:23 Collaborative FDA Letter Addressing Obesity

21:36 Advocating for the Publication of Surprising Findings

28:32 Insights from Dr. Gillett's Surgical Experience

29:34 Conclusion

Studies/References

► https://clinicaltrials.gov/study/NCT03190785#publications

► https://pubmed.ncbi.nlm.nih.gov/32092760/

► https://onlinelibrary.wiley.com/doi/full/10.1111/acel.14027

► https://acsess.onlinelibrary.wiley.com/doi/full/10.2134/ael2015.10.0007

► https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.15370

For High-quality labs:

► https://gilletthealth.com/order-lab-panels/

For information on the Gillett Health clinic, lab panels, and health coaching:

► https://GillettHealth.com

Follow Gillett Health for more content from James and Kyle

► https://instagram.com/gilletthealth

► https://www.tiktok.com/@gilletthealth

► https://twitter.com/gilletthealth

► https://www.facebook.com/gilletthealth

Follow Kyle Gillett, MD

► https://instagram.com/kylegillettmd

Follow James O’Hara, NP

► https://Instagram.com/jamesoharanp

For 10% off Gorilla Mind products including SIGMA: Use code “GH10”

► https://gorillamind.com/

For discounts on high-quality supplements

►https://www.thorne.com/u/GillettHealth

#podcast #study #discussion #science #gilletthealth

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy